3 October 2017
In a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.
3 January 2017
Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
10 November 2016
The trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.
9 August 2016
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
29 April 2016
Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
31 March 2016
Experts call for introduction of sleep guidelines in new report
5 January 2016
A patient who is the first in the UK to receive the world’s most advanced 'bionic eye' has been able to read the time for the first time in more than five years.
10 November 2015
Professor Russell Foster writes about circadian rhythm and health on the online news platform 'The Conversation'
26 October 2015
Harry Orlans will work with Robert MacLaren to develop a treatment for retinitis pigmentosa.
20 July 2015
Dominik Fischer, who completed his DPhil in our Department, received an extraordinary professorship at the Eberhard Karls University of Tübingen on Tuesday 7 July 2015.
Gene therapy gives long-term protection to photoreceptor cells in a mouse model of retinitis pigmentosa
15 July 2015
A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common inherited eye disorder.